Psychedelic-Assisted Therapy: What the Clinical Trials Are Showing

Therapy & Treatment · 3 · March 22, 2026

Psilocybin for depression, MDMA for PTSD, ketamine for treatment-resistant cases — the clinical evidence that's changing FDA policy.